Login

Financial Snapshot

Revenue
TTM
$17.42M
Gross Margin
TTM
35.57%
Net Income
TTM
-$96.03M
Current Assets
2025 Q2
$112.2M
Current Liabilities
2025 Q2
$14.07M
Current Ratio
2025 Q2
797.87%
Total Assets
2025 Q2
$120.3M
Total Liabilities
2025 Q2
$45.83M
Book Value
2025 Q2
74.51M
Cash
2025 Q2
$24.44M
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$83.93M

Stock Price

Loading...
Market Cap: $82.066 Million

About Pulsenmore Ltd

Pulsenmore Ltd. engages in research and development, production, marketing, and sale of self-scan ultrasound devices for remote clinical diagnosis and screening. The company is headquartered in Omer, Michigan. The company went IPO on 2021-06-15. The firm engaged in the field of research and development activity, production, marketing and sales worldwide of solutions and technologies that concern portable ultrasound devices for home use by the patient for a remote physical examination or monitoring using telehealth technology. he company has developed and sells two miniaturized ultrasound systems: the first is called PulseNmore ES, for performing home ultrasound tests for pregnant women; and the second is called PulseNmore FC, for performing a self-test of the size of the follicles in women who are in the process in vitro fertilization. Both systems make use of a smart mobile phone and make the test accessible without the need o visit in clinic or hospital, while being able to transfer film for the doctor, the treating medical team or the hotline online. Moreover the COmpany delivers software for its products.

Industry: Surgical & Medical Instruments & Apparatus

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support